<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01233050</url>
  </required_header>
  <id_info>
    <org_study_id>EM-05-012087</org_study_id>
    <nct_id>NCT01233050</nct_id>
  </id_info>
  <brief_title>Efficacy Comparison of Two Preoperative Skin Antisepsis Preparations in Colorectal Surgery</brief_title>
  <official_title>A Randomized Double-Blind Study of 2% Chlorhexidine Gluconate / 70% Isopropyl Alcohol vs Iodine Povacrylex [0.7% Available Iodine] / 74% Isopropyl Alcohol for Perioperative Skin Preparation in Open Elective Colorectal Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Pennsylvania</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>3M</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Pennsylvania</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Surgical site infections (SSI) are one of the most common complications in the post-operative
      patient, and the second most common health care associated infection overall. It is estimated
      that there are between 500 thousand and 1.1 million surgical site infections in the United
      States each year. Given the magnitude of the problem, prevention of surgical site infections
      is a major goal of peri-operative care. However, skin preparation prior to surgery has not
      been as rigorously examined. The primary objective of this study is to compare the efficacy
      of two FDA approved, popular peri-operative skin preparations 2% chlorhexidine gluconate /
      70% isopropyl alcohol to Iodine Povacrylex [0.7% available Iodine] / 74% Isopropyl Alcohol in
      the prevention of superficial surgical site infection. Male and female patients, age 18 years
      and older undergoing elective colorectal surgical procedures involving a laparotomy will be
      enrolled. These patients are at high risk of SSI. Eligible patients will be assessed at
      regular intervals for SSI and characterization of bacterial pathogen(s) in patients with SSI.
      Patients will remain enrolled into the study until 35 days postoperatively.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2010</start_date>
  <completion_date type="Actual">February 2015</completion_date>
  <primary_completion_date type="Actual">February 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The Primary Objective Measures the Proportion of Patients With Superficial Site Infection as Defined by the CDC.</measure>
    <time_frame>within 35 days of randomization to treatment assignment</time_frame>
    <description>The primary objective compares the efficacy of 2% chlorhexidine gluconate / 70% isopropyl alcohol (ChloraPrep) to Iodine Povacrylex [0.7% available Iodine] / 74% Isopropyl Alcohol (DuraPrep) in the prevention of superficial surgical site infection. The primary objective will be measured by the number and percentage of patients with superficial site infection as defined by the CDC.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time to Develop Surgical Site Infection</measure>
    <time_frame>within 35 days of randomization to treatment assignment</time_frame>
    <description>average time from surgery to surgical site infection diagnosis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bacterial Pathogens Present in Documented Surgical Site Infection</measure>
    <time_frame>within 35 days of randomization to treatment assignment</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number and Percentage of Participants With Deep Wound Infection</measure>
    <time_frame>within 35 days of randomization to treatment assignment</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number and Percentage of Participants With Organ Space Infection</measure>
    <time_frame>within 35 days of randomization to treatment assignment</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of Hospital Stay</measure>
    <time_frame>within 35 days of randomization to treatment assignment</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Analysis of Inappropriately Used Antibiotics</measure>
    <time_frame>within 35 days of randomization to treatment assignment</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">802</enrollment>
  <condition>Colorectal Surgery</condition>
  <arm_group>
    <arm_group_label>2% Chlorhexidine Gluconate/70% Isopropyl Alcohol</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Preoperative Skin Antisepsis Preparation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Iodine Povacrylex/74% Isopropyl Alcohol</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Preoperative Skin Antisepsis Preparation</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>2% Chlorhexidine Gluconate/70% Isopropyl Alcohol</intervention_name>
    <description>Preoperative skin antisepsis preparation</description>
    <arm_group_label>2% Chlorhexidine Gluconate/70% Isopropyl Alcohol</arm_group_label>
    <other_name>ChloraPrep</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Iodine Povacrylex/74% Isopropyl Alcohol</intervention_name>
    <description>preoperative skin antisepsis preparation</description>
    <arm_group_label>Iodine Povacrylex/74% Isopropyl Alcohol</arm_group_label>
    <other_name>DuraPrep</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. 18 years or older, male or female

          2. Undergoing any large bowel procedure with an extraction incision site(including
             ileostomy closure and Hartman's colostomy reversals).

          3. A clean-contaminated preoperative classification.

          4. Patient must have decision-making capacity and undergo appropriate informed consent
             process.

          5. Non-pregnant or post menopausal or surgically sterilized females. If of child-bearing
             age, patients must have a negative (serum or urine) pregnancy prior to surgery.

        Exclusion Criteria:

          1. Antibiotics taken within 5 days prior to surgery.

          2. Infected wound classification.

          3. Preoperative evaluation that may preclude full closure of the skin.

          4. Undergoing any bowel procedure that will not result in an extraction incision.

          5. Ongoing radiation or chemotherapy treatment.

          6. Pregnant.

          7. Refusal to accept medically indicated blood products.

          8. Current abdominal wall infection or surgical site infection from previous laparotomy /
             laparoscopy.

          9. History of laparotomy within the last 60 days.

         10. Known allergy to iodine or to chlorhexidine gluconate.

         11. Participating in a preoperative antibiotic trial.

         12. Participating in a skin antisepsis trial.

         13. Participating in Ulcerative colitis trial conflicting with this trial.

         14. Women who are breast feeding (potential for transient hypothyroidism in the nursing
             newborn).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Najjia N Mahmoud, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Pennsylvania</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital of the University of Pennsylvania</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Penn Presbyterian Medical Center</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pennsylvania Hospital</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19106</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 22, 2010</study_first_submitted>
  <study_first_submitted_qc>November 1, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 2, 2010</study_first_posted>
  <results_first_submitted>March 20, 2017</results_first_submitted>
  <results_first_submitted_qc>August 1, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">September 5, 2017</results_first_posted>
  <last_update_submitted>March 2, 2018</last_update_submitted>
  <last_update_submitted_qc>March 2, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 6, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>undergoing elective colon and /or rectal surgical procedures involving an abdominal incision</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ethanol</mesh_term>
    <mesh_term>Chlorhexidine</mesh_term>
    <mesh_term>Chlorhexidine gluconate</mesh_term>
    <mesh_term>Iodine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Chlorhexidine-Alcohol</title>
          <description>Preoperative Skin Antisepsis Preparation
2% Chlorhexidine Gluconate/70% Isopropyl Alcohol: Preoperative skin antisepsis preparation</description>
        </group>
        <group group_id="P2">
          <title>Iodine Povacrylex-Alcohol</title>
          <description>Preoperative Skin Antisepsis Preparation
Iodine Povacrylex/74% Isopropyl Alcohol: preoperative skin antisepsis preparation</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="400"/>
                <participants group_id="P2" count="402"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="392">8 participants were excluded after treatment administered due to inclusion/exclusion criteria</participants>
                <participants group_id="P2" count="396">6 participants were excluded after treatment administered due to inclusion/exclusion criteria</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="8"/>
                <participants group_id="P2" count="6"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>protocol deviation (inclusion/exclusion)</title>
              <participants_list>
                <participants group_id="P1" count="8"/>
                <participants group_id="P2" count="6"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Chlorhexidine-Alcohol arm - 8 participants were excluded after treatment administered due to inclusion/exclusion criteria
Iodine Povacrylex-Alcohol Arm - 6 participants were excluded after treatment administered due to inclusion/exclusion criteria</population>
      <group_list>
        <group group_id="B1">
          <title>Chlorhexidine-Alcohol</title>
          <description>Preoperative Skin Antisepsis Preparation
2% Chlorhexidine Gluconate/70% Isopropyl Alcohol: Preoperative skin antisepsis preparation</description>
        </group>
        <group group_id="B2">
          <title>Iodine Povacrylex-Alcohol</title>
          <description>Preoperative Skin Antisepsis Preparation
Iodine Povacrylex/74% Isopropyl Alcohol: preoperative skin antisepsis preparation</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="392"/>
            <count group_id="B2" value="396"/>
            <count group_id="B3" value="788"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="57.33" spread="16.65"/>
                    <measurement group_id="B2" value="56.75" spread="15.81"/>
                    <measurement group_id="B3" value="57.04" spread="16.22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="202"/>
                    <measurement group_id="B2" value="203"/>
                    <measurement group_id="B3" value="405"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="190"/>
                    <measurement group_id="B2" value="193"/>
                    <measurement group_id="B3" value="383"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>White Non-Hispanic</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="307"/>
                    <measurement group_id="B2" value="322"/>
                    <measurement group_id="B3" value="629"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>African American or Black</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="64"/>
                    <measurement group_id="B2" value="55"/>
                    <measurement group_id="B3" value="119"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Asian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hispanic or Latino</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Other</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unknown</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>The Primary Objective Measures the Proportion of Patients With Superficial Site Infection as Defined by the CDC.</title>
        <description>The primary objective compares the efficacy of 2% chlorhexidine gluconate / 70% isopropyl alcohol (ChloraPrep) to Iodine Povacrylex [0.7% available Iodine] / 74% Isopropyl Alcohol (DuraPrep) in the prevention of superficial surgical site infection. The primary objective will be measured by the number and percentage of patients with superficial site infection as defined by the CDC.</description>
        <time_frame>within 35 days of randomization to treatment assignment</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Chlorhexidine-Alcohol</title>
            <description>Preoperative Skin Antisepsis Preparation
2% Chlorhexidine Gluconate/70% Isopropyl Alcohol: Preoperative skin antisepsis preparation</description>
          </group>
          <group group_id="O2">
            <title>Iodine Povacrylex-Alcohol</title>
            <description>Preoperative Skin Antisepsis Preparation
Iodine Povacrylex/74% Isopropyl Alcohol: preoperative skin antisepsis preparation</description>
          </group>
        </group_list>
        <measure>
          <title>The Primary Objective Measures the Proportion of Patients With Superficial Site Infection as Defined by the CDC.</title>
          <description>The primary objective compares the efficacy of 2% chlorhexidine gluconate / 70% isopropyl alcohol (ChloraPrep) to Iodine Povacrylex [0.7% available Iodine] / 74% Isopropyl Alcohol (DuraPrep) in the prevention of superficial surgical site infection. The primary objective will be measured by the number and percentage of patients with superficial site infection as defined by the CDC.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="392"/>
                <count group_id="O2" value="396"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="40"/>
                    <measurement group_id="O2" value="46"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time to Develop Surgical Site Infection</title>
        <description>average time from surgery to surgical site infection diagnosis</description>
        <time_frame>within 35 days of randomization to treatment assignment</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Chlorhexidine-Alcohol</title>
            <description>Preoperative Skin Antisepsis Preparation
2% Chlorhexidine Gluconate/70% Isopropyl Alcohol: Preoperative skin antisepsis preparation</description>
          </group>
          <group group_id="O2">
            <title>Iodine Povacrylex-Alcohol</title>
            <description>Preoperative Skin Antisepsis Preparation
Iodine Povacrylex/74% Isopropyl Alcohol: preoperative skin antisepsis preparation</description>
          </group>
        </group_list>
        <measure>
          <title>Time to Develop Surgical Site Infection</title>
          <description>average time from surgery to surgical site infection diagnosis</description>
          <units>days</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="392"/>
                <count group_id="O2" value="396"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.0" spread="0.7"/>
                    <measurement group_id="O2" value="8.7" spread="0.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Bacterial Pathogens Present in Documented Surgical Site Infection</title>
        <time_frame>within 35 days of randomization to treatment assignment</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Chlorhexidine-Alcohol</title>
            <description>Preoperative Skin Antisepsis Preparation
2% Chlorhexidine Gluconate/70% Isopropyl Alcohol: Preoperative skin antisepsis preparation</description>
          </group>
          <group group_id="O2">
            <title>Iodine Povacrylex-Alcohol</title>
            <description>Preoperative Skin Antisepsis Preparation
Iodine Povacrylex/74% Isopropyl Alcohol: preoperative skin antisepsis preparation</description>
          </group>
        </group_list>
        <measure>
          <title>Bacterial Pathogens Present in Documented Surgical Site Infection</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="43"/>
                <count group_id="O2" value="26"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="43"/>
                    <measurement group_id="O2" value="26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number and Percentage of Participants With Deep Wound Infection</title>
        <time_frame>within 35 days of randomization to treatment assignment</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Chlorhexidine-Alcohol</title>
            <description>Preoperative Skin Antisepsis Preparation
2% Chlorhexidine Gluconate/70% Isopropyl Alcohol: Preoperative skin antisepsis preparation</description>
          </group>
          <group group_id="O2">
            <title>Iodine Povacrylex-Alcohol</title>
            <description>Preoperative Skin Antisepsis Preparation
Iodine Povacrylex/74% Isopropyl Alcohol: preoperative skin antisepsis preparation</description>
          </group>
        </group_list>
        <measure>
          <title>Number and Percentage of Participants With Deep Wound Infection</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="392"/>
                <count group_id="O2" value="396"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="22"/>
                    <measurement group_id="O2" value="28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number and Percentage of Participants With Organ Space Infection</title>
        <time_frame>within 35 days of randomization to treatment assignment</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Chlorhexidine-Alcohol</title>
            <description>Preoperative Skin Antisepsis Preparation
2% Chlorhexidine Gluconate/70% Isopropyl Alcohol: Preoperative skin antisepsis preparation</description>
          </group>
          <group group_id="O2">
            <title>Iodine Povacrylex-Alcohol</title>
            <description>Preoperative Skin Antisepsis Preparation
Iodine Povacrylex/74% Isopropyl Alcohol: preoperative skin antisepsis preparation</description>
          </group>
        </group_list>
        <measure>
          <title>Number and Percentage of Participants With Organ Space Infection</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="392"/>
                <count group_id="O2" value="396"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="20"/>
                    <measurement group_id="O2" value="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Length of Hospital Stay</title>
        <time_frame>within 35 days of randomization to treatment assignment</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Chlorhexidine-Alcohol</title>
            <description>Preoperative Skin Antisepsis Preparation
2% Chlorhexidine Gluconate/70% Isopropyl Alcohol: Preoperative skin antisepsis preparation</description>
          </group>
          <group group_id="O2">
            <title>Iodine Povacrylex-Alcohol</title>
            <description>Preoperative Skin Antisepsis Preparation
Iodine Povacrylex/74% Isopropyl Alcohol: preoperative skin antisepsis preparation</description>
          </group>
        </group_list>
        <measure>
          <title>Length of Hospital Stay</title>
          <units>days</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="392"/>
                <count group_id="O2" value="396"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.0" spread="3.9"/>
                    <measurement group_id="O2" value="6.8" spread="3.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Analysis of Inappropriately Used Antibiotics</title>
        <time_frame>within 35 days of randomization to treatment assignment</time_frame>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Chlorhexidine-Alcohol</title>
          <description>Preoperative Skin Antisepsis Preparation
2% Chlorhexidine Gluconate/70% Isopropyl Alcohol: Preoperative skin antisepsis preparation</description>
        </group>
        <group group_id="E2">
          <title>Iodine Povacrylex-Alcohol</title>
          <description>Preoperative Skin Antisepsis Preparation
Iodine Povacrylex/74% Isopropyl Alcohol: preoperative skin antisepsis preparation</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="392"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="396"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="392"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="396"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="392"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="396"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Najjia Mahmoud, MD, Cheif of Colorectal Surgery</name_or_title>
      <organization>Penn Medicine</organization>
      <phone>(215) 662-2078</phone>
      <email>najjia.mahmoud@uphs.upenn.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

